Showing 39,601 - 39,620 results of 103,901 for search '(( e point decrease ) OR ( 5 ((((teer decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.52s Refine Results
  1. 39601

    Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes by Wei-Lun Tang (4014314)

    Published 2017
    “…The dosage form for Mef is mostly available as adult tablets, and thus children under the age of 5 suffer from poor medication adherence. We have developed a stable, rapidly dissolvable, and palatable pediatric formulation for Mef using liposomes composed of 1,2-distearoyl-<i>sn</i>-glycero-3-phosphocholine (DSPC) and cholesterol with a mean diameter of ∼110 nm. …”
  2. 39602

    Table_1_Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort... by Haofei Hu (8534712)

    Published 2022
    “…Further, compared to non-HTG subjects with eGFR ≥ 116.56 ml/min/1.73 m<sup>2</sup>, participants with HTG and eGFR < 82.88 ml/min/1.73 m<sup>2</sup> had about a fourfold increase in the risk (HR = 4.852 95% CI: 3.943–5.970) of NAFLD.…”
  3. 39603

    Use of quantitative proteomics identifies a putative TvROM1 substrate. by Angelica M. Riestra (838706)

    Published 2015
    “…<b>(C)</b> The predicted TM domains of the five putative substrates identified in <b>A</b>, and the percent decrease in protein levels with 3,4-DCI <i>vs</i>. …”
  4. 39604

    Lymphatic density (LD; a) and blood vessel density (BD; b) in the myocardium by Y Ishikawa (46340)

    Published 2011
    “…The values of BD are 2693.4 ± 197.0 in Normal, 1689.9 ± 640.7 in Stage I, 571.4 ± 478.3 in Stage II, 51.8 ± 30.5 in Stage III, 1430.8 ± 323.1 in Stage IV, 1292.7 ± 153.1 in Stage V, 509.9 ± 276.3 in Stage VI and 130.5 ± 83.8 in Stage VII. …”
  5. 39605

    Interpretation on the model parameters. by Alexandre Blake (3837595)

    Published 2025
    “…<div><p>Cholera is a bacterial water-borne diarrheal disease transmitted via the fecal-oral route that causes high morbidity in sub-Saharan Africa and Asia. …”
  6. 39606

    Morphological changes caused by the lateral compression. by Heidi Peussa (12769831)

    Published 2022
    “…(D) Orthogonal projections of the actin chromobody-mCherry expressing MCDK II cell layer at different time points showing packing and thickening of the cells (scale bar 30 μm, inverted gray scale LUT), and (E) corresponding cell layer thicknesses during compression. …”
  7. 39607
  8. 39608
  9. 39609

    DataSheet1_Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach.pdf by Punyabhorn Rattanacheeworn (11447329)

    Published 2021
    “…AUC and C<sub>max</sub> GMR (95%CI) of atorvastatin, another CYP3A substrate, was increased 2.14 (1.52–3.02) fold in healthy elderly and 4.15 (2.98–5.79) fold in elderly patients with CKD, indicating decreased CYP3A activity related to ageing. …”
  10. 39610
  11. 39611
  12. 39612

    Quantifying the Contribution of the Dispersion Interaction and Hydrogen Bonding to the Anisotropic Elastic Properties of Chitin and Chitosan by Pan Chen (385477)

    Published 2022
    “…Switching off the dispersion correction led to a decrease in modulus by up to 63%, depending on the direction. …”
  13. 39613

    Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study by Eric H. Chou (8293107)

    Published 2020
    “…Mortality from all sites of infection has decreased significantly (trend p<0.001). Skin and skin structure infection had the fastest declining rate (annual decrease: 5.5%) followed by primary bacteremia (annual decrease: 5.3%) and catheter related bloodstream infection (annual decrease: 4.8%).…”
  14. 39614
  15. 39615
  16. 39616
  17. 39617
  18. 39618
  19. 39619
  20. 39620

    DataSheet_1_Icanbelimod (CBP-307), a next-generation Sphingosine-1-phosphate receptor modulator, in healthy men: pharmacokinetics, pharmacodynamics, safety, and tolerability in a r... by Jason Lickliter (18073228)

    Published 2024
    “…After single-dose 0.5 mg, although a high-fat breakfast versus fasting did not affect maximal decrease, lymphocyte counts tended to be lower after breakfast across most timepoints up to 72 hours. …”